Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

McGill University

Status: Completed

Conditions: Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Exacerbation

Treatments: Device: Biometric wearable devices

Study type: Observational

Funder types: Other

Identifiers

NCT05776654

2023-8851

Details and patient eligibility

About

The purpose the study is to successfully characterize the recovery phase of acute exacerbations of COPD in the outpatient setting using remotely captured physiologic data from wearable devices, to compare this with patient self-reported symptom data, to determine which physiologic variable(s) best correspond with AECOPD recovery, and to further document the feasibility, data quantity, data quality, and COPD outpatient usability experience with wearable devices.

Enrollment: 21 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Males/females, age ≥40, former/current smokers with ≥10 pack-year smoking history
2. Currently experiencing/receiving treatment for a physician-diagnosed AECOPD
3. Forced expired volume in the first second (FEV1) / Forced vital capacity (FVC) < 0.7 (GOLD 1-4)
4. Ability to provide informed consent

Exclusion criteria

1. No existing COPD diagnosis
2. History of cardiac arrhythmia
3. Presence of pacemaker/defibrillator
4. Any medical/cognitive/functional condition which renders inability to don/doff/recharge devices and complete symptom questionnaire
5. Have already received 4 or more days of consecutive corticosteroid and/or antibiotic therapy since presenting to medical attention for their AECOPD

Trial design

21 participants in 1 patient group

COPD cohort

Description:

Patients with COPD currently experiencing and receiving treatment for an exacerbation.

Treatment:

Device: Biometric wearable devices